Molecular xenomonitoring as an indicator of microfilaraemia prevalence for lymphatic filariasis in Samoa in 2019.
Lymphatic filariasis elimination
Surveillance
Vector-borne disease
Journal
Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774
Informations de publication
Date de publication:
09 Sep 2024
09 Sep 2024
Historique:
received:
05
06
2024
accepted:
21
08
2024
medline:
10
9
2024
pubmed:
10
9
2024
entrez:
9
9
2024
Statut:
epublish
Résumé
Lymphatic filariasis (LF) is a globally significant, vector-borne, neglected tropical disease that can result in severe morbidity and disability. As the World Health Organization (WHO) Global Programme to Eliminate Lymphatic Filariasis makes progress towards LF elimination, there is greater need to develop sensitive strategies for post-intervention surveillance. Molecular xenomonitoring (MX), the detection of pathogen DNA in vectors, may provide a sensitive complement to traditional human-based surveillance techniques, including detection of circulating filarial antigen and microfilaraemia (Mf). This study aims to explore the relationship between human Mf prevalence and the prevalence of polymerase chain reaction (PCR)-positive mosquitoes using MX. This study compared Mf and MX results from a 2019 community-based survey conducted in 35 primary sampling units (PSUs) in Samoa. This study also investigated concordance between presence and absence of PCR-positive mosquitoes and Mf-positive participants at the PSU level, and calculated sensitivity and negative predictive values for each indicator using presence of any Mf-positive infection in humans or PCR-positive mosquitoes as a reference. Correlation between prevalence of filarial DNA in mosquitoes and Mf in humans was estimated at the PSU and household/trap level using mixed-effect Bayesian multilevel regression analysis. Mf-positive individuals were identified in less than half of PSUs in which PCR-positive mosquito pools were present (13 of 28 PSUs). Prevalence of PCR-positive mosquitoes (each species separately) was positively correlated with Mf prevalence in humans at the PSU level. Analysed at the species level, only Aedes polynesiensis demonstrated strong evidence of positive correlation (r) with human Mf prevalence at both PSU (r: 0.5, 95% CrI 0.1-0.8) and trap/household levels (r: 0.6, 95% CrI 0.2-0.9). Findings from this study demonstrate that MX can be a sensitive surveillance method for identifying residual infection in low Mf prevalence settings. MX identified more locations with signals of transmission than Mf-testing. Strong correlation between estimated PCR-positive mosquitoes in the primary vector species and Mf in humans at small spatial scales demonstrates the utility of MX as an indicator for LF prevalence in Samoa and similar settings. Further investigation is needed to develop MX guidelines to strengthen the ability of MX to inform operational decisions.
Sections du résumé
BACKGROUND
BACKGROUND
Lymphatic filariasis (LF) is a globally significant, vector-borne, neglected tropical disease that can result in severe morbidity and disability. As the World Health Organization (WHO) Global Programme to Eliminate Lymphatic Filariasis makes progress towards LF elimination, there is greater need to develop sensitive strategies for post-intervention surveillance. Molecular xenomonitoring (MX), the detection of pathogen DNA in vectors, may provide a sensitive complement to traditional human-based surveillance techniques, including detection of circulating filarial antigen and microfilaraemia (Mf). This study aims to explore the relationship between human Mf prevalence and the prevalence of polymerase chain reaction (PCR)-positive mosquitoes using MX.
METHODS
METHODS
This study compared Mf and MX results from a 2019 community-based survey conducted in 35 primary sampling units (PSUs) in Samoa. This study also investigated concordance between presence and absence of PCR-positive mosquitoes and Mf-positive participants at the PSU level, and calculated sensitivity and negative predictive values for each indicator using presence of any Mf-positive infection in humans or PCR-positive mosquitoes as a reference. Correlation between prevalence of filarial DNA in mosquitoes and Mf in humans was estimated at the PSU and household/trap level using mixed-effect Bayesian multilevel regression analysis.
RESULTS
RESULTS
Mf-positive individuals were identified in less than half of PSUs in which PCR-positive mosquito pools were present (13 of 28 PSUs). Prevalence of PCR-positive mosquitoes (each species separately) was positively correlated with Mf prevalence in humans at the PSU level. Analysed at the species level, only Aedes polynesiensis demonstrated strong evidence of positive correlation (r) with human Mf prevalence at both PSU (r: 0.5, 95% CrI 0.1-0.8) and trap/household levels (r: 0.6, 95% CrI 0.2-0.9).
CONCLUSIONS
CONCLUSIONS
Findings from this study demonstrate that MX can be a sensitive surveillance method for identifying residual infection in low Mf prevalence settings. MX identified more locations with signals of transmission than Mf-testing. Strong correlation between estimated PCR-positive mosquitoes in the primary vector species and Mf in humans at small spatial scales demonstrates the utility of MX as an indicator for LF prevalence in Samoa and similar settings. Further investigation is needed to develop MX guidelines to strengthen the ability of MX to inform operational decisions.
Identifiants
pubmed: 39252131
doi: 10.1186/s13071-024-06463-7
pii: 10.1186/s13071-024-06463-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
382Subventions
Organisme : National Health and Medical Research Council
ID : APP1193826
Informations de copyright
© 2024. The Author(s).
Références
Ottesen EA, Duke BOL, Karam M, Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. World Health Organ Bull. 1997;75:491–503.
World Health Organization: Global programme to eliminate lymphatic filariasis: progress report, 2022 – Programme mondial pour l’élimination de la filariose lymphatique: rapport de situation, 2022. In: Weekly Epidemiological Record = Relevé épidémiologique hebdomadaire, vol. 98: World Health Organization = Organisation mondiale de la Santé; 2023; 489–501.
World Health Organization: Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis. https://www.who.int/publications/i/item/9789241550161 (2017). Accessed 8 Sep 2023.
World Health Organization: Lymphatic filariasis. https://www.who.int/news-room/fact-sheets/detail/lymphatic-filariasis (2023). Accessed 8 Sep 2023.
World Health Organization: Monitoring and Epidemiological Assessment of Mass Drug Administration in the Global Programme to Eliminate Lymphatic Filariasis: A Manual for National Elimination Programmes. https://apps.who.int/iris/handle/10665/44580 (2011). Accessed 8 Sep 2023.
Stolk WA, Coffeng LE, Bolay FK, Eneanya OA, Fischer PU, Hollingsworth TD, et al. Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in Africa. PLoS Negl Trop Dis. 2022. 16(12): p. e0010953. https://doi.org/10.1371/journal.pntd.0010953 .
doi: 10.1371/journal.pntd.0010953
pubmed: 36508458
pmcid: 9779720
Graves PM, Sheridan S, Scott J, Sam FA-L, Naseri T, Thomsen R, et al. Triple-drug treatment is effective for lymphatic filariasis microfilaria clearance in Samoa. Trop Med Infect Dis. 2021;6(2):44. https://doi.org/10.3390/tropicalmed6020044 .
doi: 10.3390/tropicalmed6020044
pubmed: 34287387
pmcid: 8293346
Ottesen EA. Lymphatic filariasis: treatment, control and elimination. In: Molyneux D, editor. Advances in parasitology: Control of Human Parasitic Diseases. Cambridge: Academic Press; 2006;61:395–441.
doi: 10.1016/S0065-308X(05)61010-X
McPherson B, Mayfield HJ, McLure A, Gass K, Naseri T, Thomsen R, et al. Evaluating molecular xenomonitoring as a tool for lymphatic filariasis surveillance in samoa, 2018–2019. Trop Med Infect Dis. 2022;7(8):203. https://doi.org/10.3390/tropicalmed7080203 .
doi: 10.3390/tropicalmed7080203
pubmed: 36006295
pmcid: 9414188
Pilotte N, Unnasch TR, Williams SA. The current status of molecular xenomonitoring for lymphatic filariasis and onchocerciasis. Trends Parasitol. 2017;33:788–98. https://doi.org/10.1016/j.pt.2017.06.008 .
doi: 10.1016/j.pt.2017.06.008
pubmed: 28756911
Lau CL, Won KY, Lammie PJ, Graves PM. Lymphatic filariasis elimination in American Samoa: evaluation of molecular xenomonitoring as a surveillance tool in the endgame. PLoS Negl Trop Dis. 2016;10(11):e0005108. https://doi.org/10.1371/journal.pntd.0005108 .
doi: 10.1371/journal.pntd.0005108
pubmed: 27802280
pmcid: 5089733
Rao RU, Samarasekera SD, Nagodavithana KC, Punchihewa MW, Dassanayaka TM, Gamini PKD, et al. Programmatic use of molecular xenomonitoring at the level of evaluation units to assess persistence of lymphatic filariasis in Sri Lanka. PLoS Negl Trop Dis. 2016. https://doi.org/10.1371/journal.pntd.0004722 .
doi: 10.1371/journal.pntd.0004722
pubmed: 27196431
pmcid: 4873130
Subramanian S, Jambulingam P, Chu BK, Sadanandane C, Vasuki V, Srividya A, et al. Application of a household-based molecular xenomonitoring strategy to evaluate the lymphatic filariasis elimination program in Tamil Nadu. India PLoS Negl Trop Dis. 2017;11(4):e0005519. https://doi.org/10.1371/journal.pntd.0005519 .
doi: 10.1371/journal.pntd.0005519
pubmed: 28406927
Schmaedick MA, Koppel AL, Pilotte N, Torres M, Williams SA, Dobson SL, et al. Molecular xenomonitoring using mosquitoes to map lymphatic filariasis after mass drug administration in American Samoa. PLoS Negl Trop Dis. 2014;8(8):e3087. https://doi.org/10.1371/journal.pntd.0003087 .
doi: 10.1371/journal.pntd.0003087
pubmed: 25122037
pmcid: 4133231
Subramanian S, Jambulingam P, Krishnamoorthy K, Sivagnaname N, Sadanandane C, Vasuki V, et al. Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: field validation in an evaluation unit in India. PLoS Negl Trop Dis. 2020;14(1):e0007862–25. https://doi.org/10.1371/journal.pntd.0007862 .
doi: 10.1371/journal.pntd.0007862
pubmed: 33095805
pmcid: 7641468
Owusu IO, de Souza DK, Anto F, Wilson MD, Boakye DA, Bockarie MJ, et al. Evaluation of human and mosquito based diagnostic tools for defining endpoints for elimination of Anopheles transmitted lymphatic filariasis in Ghana. Trans R Soc Trop Med Hyg. 2015;109:628–35. https://doi.org/10.1093/trstmh/trv070 .
doi: 10.1093/trstmh/trv070
pubmed: 26385935
Kimura E, Penaia L, Spears GFS. The efficacy of annual single-dose treatment with diethylcarbamazine citrate against diurnally subperiodic bancroftian filariasis in Samoa. Bull World Health Organ. 1985;63:1097–106.
pubmed: 3914925
pmcid: 2536478
Ichimori K, Tupuimalagi-Toelupe P, Toeaso Iosia V, Graves MP. Wuchereria bancrofti filariasis control in Samoa before PacELF (pacific programme to eliminate lymphatic filariasis). Trop Med Health. 2007;35:261–9. https://doi.org/10.2149/tmh.35.261 .
doi: 10.2149/tmh.35.261
Graves PM, Joseph H, Coutts SP, Mayfield HJ, Maiava F, Ah Leong-Lui TA, et al. Chapter two—control and elimination of lymphatic filariasis in Oceania: prevalence, geographical distribution, mass drug administration, and surveillance in Samoa, 1998–2017. In: Rollinson D, Stothard R, et al., editors. Advances in parasitology, vol. 114. Cambridge: Academic Press; 2021. p. 27–73.
Ichimori K, Graves PM. Overview of PacELF—the pacific programme for the elimination of lymphatic filariasis. Trop Med Health. 2017;45:34. https://doi.org/10.1186/s41182-017-0075-4 .
doi: 10.1186/s41182-017-0075-4
pubmed: 29118654
pmcid: 5664808
World Health Organization: Samoa rolls out triple drug therapy to accelerate elimination of lymphatic filariasis. https://www.who.int/news/item/24-08-2018-samoa-rolls-out-triple-drug-therapy-to-accelerate-elimination-of-lymphatic-filariasis#:~:text=Samoa%20has%20become%20the%20first%20country%20to%20implement,is%20expected%20to%20be%20completed%20by%2026%20August (2018). Accessed 20 Sept 2023.
Statistics SBo: 2016 Census—Population and Demography https://www.sbs.gov.ws/census/ (Date unknown). Accessed 8 Sept 2023.
Division GoSM: Climate of Samoa. http://www.samet.gov.ws/index.php/climate-of-samoa . Accessed 20 Sept 2023.
Lau CL, Meder K, Mayfield HJ, Kearns T, McPherson B, Naseri T, et al. Lymphatic filariasis epidemiology in Samoa in 2018: geographic clustering and higher antigen prevalence in older age groups. PLoS Negl Trop Dis. 2020;14(12):e0008927. https://doi.org/10.1371/journal.pntd.0008927 .
doi: 10.1371/journal.pntd.0008927
pubmed: 33370264
pmcid: 7872281
World Health Organization: Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis. Learners' guide. https://www.who.int/publications/i/item/9789241505451 (2013). Accessed Jul 1 2023.
Zulch MF, Pilotte N, Grant JR, Minetti C, Reimer LJ, Williams SA. Selection and exploitation of prevalent, tandemly repeated genomic targets for improved real-time PCR-based detection of Wuchereria bancrofti and Plasmodium falciparum in mosquitoes. PLoS ONE. 2020;15(5):e0232325. https://doi.org/10.1371/journal.pone.0232325 .
doi: 10.1371/journal.pone.0232325
pubmed: 32357154
pmcid: 7194414
Mercer DR, Marie J, Bossin H, Faaruia M, Tetuanui A, Sang MC, et al. Estimation of population size and dispersal of aedes polynesiensis on toamaro motu, French polynesia. J Med Entemol. 2014;49:971–80. https://doi.org/10.1603/me11234 .
doi: 10.1603/me11234
R Core Team: R: A language and environment for statistical computing: R Foundation for Statistical Computing. https://www.R-project.org (2023). Accessed 20 May 2024.
Posit team: RStudio: Integrated Development Environment for R. http://www.posit.co/ (2023). Accessed 20 May 2024.
McLure A, O’Neill B, Mayfield H, Lau C, McPherson B. PoolTestR: An R package for estimating prevalence and regression modelling for molecular xenomonitoring and other applications with pooled samples. Environ Model Softw. 2021;145:105158. https://doi.org/10.1016/j.envsoft.2021.105158 .
doi: 10.1016/j.envsoft.2021.105158
World Health Organization: Diagnostic test for surveillance of lymphatic filariasis: target product profile. https://www.who.int/publications/i/item/9789240018648 (2021). Accessed 20 May 2024.
Farrell PJ, MacGibbon B, Tomberlin TJ. Empirical bayes estimators of small area proportions in multistage designs. Stat Sin. 1997;7:1065–83.
Ghosh M, Natarajan K, Stroud TWF, Carlin BP. Generalized linear models for small-area estimation. JASA. 1998;93:273–82. https://doi.org/10.1080/01621459.1998.10474108 .
doi: 10.1080/01621459.1998.10474108
Moretti A. Estimation of small area proportions under a bivariate logistic mixed model. Qual Quant. 2023;57:3663–84. https://doi.org/10.1007/s11135-022-01530-6 .
doi: 10.1007/s11135-022-01530-6
Pfeffermann D. New important developments in small area estimation. Stat Sci. 2013;28:40–68.
doi: 10.1214/12-STS395
Villanueva RAM, Chen ZJ. Elegant graphics for data analysis. Meas Interdiscip Res Perspect. 2019;17:160–7. https://doi.org/10.1080/15366367.2019.1565254 .
doi: 10.1080/15366367.2019.1565254
Pryce J, Reimer LJ. Evaluating the diagnostic test accuracy of molecular xenomonitoring methods for characterizing community burden of lymphatic filariasis. Clin Infect Dis. 2021;72:S203–9. https://doi.org/10.1093/cid/ciab197 .
doi: 10.1093/cid/ciab197
pubmed: 33906238
pmcid: 8201559
Gan SJ, Leong YQ, Bin Barhanuddin MFH, Wong ST, Wong SF, Mak JW, et al. Dengue fever and insecticide resistance in Aedes mosquitoes in Southeast Asia: a review. Parasites Vectors. 2021;14:315. https://doi.org/10.1186/s13071-021-04785-4 .
doi: 10.1186/s13071-021-04785-4
pubmed: 34112220
pmcid: 8194039
Hamer GL, Anderson TK, Donovan DJ, Brawn JD, Krebs BL, Gardner AM, et al. Dispersal of adult culex mosquitoes in an urban West Nile virus hotspot: a mark-capture study incorporating stable isotope enrichment of natural larval habitats. PLoS Negl Trop Dis. 2014;8(3):e2768. https://doi.org/10.1371/journal.pntd.0002768 .
doi: 10.1371/journal.pntd.0002768
pubmed: 25211133
pmcid: 4161329